Nagalaxmi Vemalapally

发表

Breast cancer mutations HER2V777L and PIK3CAH1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance

S. Achilefu, R. Bose, Shunqiang Li, 2022, bioRxiv.

DEVELOPMENT OF PEDIATRIC MODEL OF HEMATOPOIETIC ACUTE RADIATION SYNDROME (H-ARS) AND COUNTERMEASURE TESTING USING THE GÖTTINGEN MINIPIG

D. L. Bolduc, A. Kaur, M. Moroni, 2017 .

Neratinib Synergizes with Trastuzumab Antibody Drug Conjugate or with Vinorelbine to Treat HER2 Mutated Breast Cancer Patient Derived Xenografts and Organoids

J. Monsey, L. Eli, Tina M Primeau, 2023, bioRxiv.